MG132 enhances the radiosensitivity of lung cancer cells in vitro and in vivo
MG132 enhances the radiosensitivity of lung cancer cells in vitro and in vivo
复制标题
MG132增强肺癌细胞体内外放射敏感性
DOI:
10.3892/or.2015.4169
复制
发表时间:
2015-10-01
期刊:
影响因子:
4.2
通讯作者:
Cao, Jianping
中科院分区:
文献类型:
--
作者:
Zhu, Wei;Liu, Jing;Cao, Jianping
Radiotherapy is a common treatment modality for lung cancer, however, radioresistance remains a fundamental barrier to attaining the maximal efficacy. Cancer cells take advantage of the ubiquitin-proteasome system (UPS) for increased proliferation and decreased apoptotic cell death. MG132 (carbobenzoxyl-leucinyl-leucinyl-leucinal-H), a specific and selective reversible inhibitor of the 26S proteasome, has shown anticancer effect in multiple types of cancers. Previously, we have reported that MG132 enhances the anti-growth and anti-metastatic effects of irradiation in lung cancer cells. However, whether MG132 can enhance the radiosensitivity in lung cancer cells in vitro and in vivo is still unknown. In this study, we found that MG132 increased apoptosis and dicentric chromosome ratio of A549 and H1299 cells treated by irradiation. Radiation-induced NF-kappa B expression and I kappa B alpha phosphorylation was attenuated in MG132 plus irradiation-treated cells. The in vivo model of H1299 xenografts of nude mice showed that the tumor size of MG132 plus irradiation treated xenografts was smaller than that of irradiation, MG132 or the control group. Moreover, MG132 plus irradiation group showed significant reduced Ki67 expression. Taken together, these results demonstrate that MG132 enhances the radiosensitivity through multiple mechanisms in vitro and in vivo.